Gayathri Kallukaran is a Junior Journalist with Eastern Eye. She has a Master’s degree in Journalism and Mass Communication from St. Paul’s College, Bengaluru, and brings over five years of experience in content creation, including two years in digital journalism. She covers stories across culture, lifestyle, travel, health, and technology, with a creative yet fact-driven approach to reporting. Known for her sensitivity towards human interest narratives, Gayathri’s storytelling often aims to inform, inspire, and empower. Her journey began as a layout designer and reporter for her college’s daily newsletter, where she also contributed short films and editorial features. Since then, she has worked with platforms like FWD Media, Pepper Content, and Petrons.com, where several of her interviews and features have gained spotlight recognition. Fluent in English, Malayalam, Tamil, and Hindi, she writes in English and Malayalam, continuing to explore inclusive, people-focused storytelling in the digital space.
Users of the popular weight loss drug Ozempic are reportedly experiencing a new and unexpected side effect, now being referred to as “Ozempic teeth”. The term covers a range of dental problems such as dry mouth, bad breath, gum disease, and tooth decay.
According to the Daily Mail, experts have linked these issues to reduced saliva production, which may be a consequence of the drug’s appetite-suppressing effects. Ozempic, originally developed to treat type 2 diabetes, has become widely known for its role in supporting weight loss. However, the reduction in food intake that often accompanies its use may affect oral health.
Cosmetic dermatologist Dr Michele Green explained that eating stimulates the salivary glands, which helps protect teeth. “Saliva is crucial for protecting teeth, as it helps remove food particles, neutralises acids produced by bacteria in the mouth, and provides essential minerals that strengthen tooth enamel. When saliva levels are insufficient, the risk of cavities and tooth decay significantly increases,” she said.
Dr Green added that anecdotal evidence suggests Ozempic and similar drugs may contribute to dry mouth by limiting saliva production, thereby impairing the mouth’s natural ability to clean itself.
Further complications arise from some of the more common side effects of the drug, such as nausea, vomiting, and diarrhoea. Dentist Dr Victoria Holden told The Independent that vomiting poses serious risks to dental health due to stomach acid. “The stomach is very acidic, and if the patients are having that acid come up into their mouth, then it really is quite damaging to the teeth,” she said.
Dr Holden noted that Ozempic slows digestion, meaning food remains in the stomach for longer, which can lead to acid reflux. The resulting exposure of teeth to stomach acid can accelerate enamel erosion and other dental problems. She recommended consulting a medical professional if acid reflux occurs, warning that repairing acid damage to teeth can be both complex and costly.
Another concern linked to reduced food intake is nutritional deficiency. Dr Holden explained that insufficient nutrients could further impact oral health, contributing to discomfort and increasing the risk of dental issues.
“Ozempic teeth” is the latest in a series of terms coined to describe side effects associated with the drug. Others include “Ozempic mouth”, which involves changes in the appearance of the lips and surrounding skin, such as wrinkles, folds at the mouth’s corners, and sagging along the jawline.
Additionally, the term “Ozempic face” has been used to describe the prematurely aged look that some patients develop after rapid weight loss, often marked by gauntness and loss of volume in the face. “Ozempic butt” refers to the sagging of the rear area due to fat loss.
While Ozempic has proved effective for many in managing weight, these emerging side effects are prompting calls for more awareness about the broader impacts of the medication. Medical experts continue to advise users to discuss potential risks with healthcare providers before beginning or continuing treatment.
October marks Menopause Awareness Month, with World Menopause Day on 18 October.
South Asian women often face earlier menopause, more severe symptoms, and higher health risks.
Cultural stigma and silence leave many women isolated and unsupported.
The Sattva Collective CIC is the UK’s first organisation focused on South Asian women and menopause.
Founded by coach Kiran Singh, it provides safe spaces, resources, and monthly Midlife Circles.
Plans underway for a Midlife & Menopause Summit in October 2026.
Awareness is key: “Silence leads to shame. Awareness leads to empowerment.”
This October, the world observes Menopause Awareness Month, with World Menopause Day on 18th October. For many South Asian women, this is more than a health milestone, it is an opportunity to finally challenge silence, stigma, and cultural barriers that have silenced generations before us.
Menopause is universal. But its impact is not. Research shows that South Asian women often enter menopause earlier, with more severe symptoms and higher risks of diabetes and heart disease. Yet in many South Asian communities, menopause remains an unspoken subject, whispered about in kitchens, dismissed as “just part of ageing,” or hidden entirely.
The result? Women endure not only the physical changes of menopause but also isolation and shame.
The Sattva Collective CIC: A first of its kind
The Sattva Collective CIC (.www.thesattvacollective.org) is the UK’s first Community Interest Company dedicated specifically to South Asian women, midlife, and menopause. Founded by Kiran Singh (https://kiransinghuk.com/), herself a certified Midlife Lifestyle Coach and Menopause Wellness Coach, the organisation exists to create safe, culturally sensitive spaces where women can access education, share experiences, and reclaim dignity in midlife.
Through monthly Midlife Circle meet-ups, an online resource hub, and regular awareness campaigns, The Sattva Collective is making sure South Asian women know: you are not alone.
Looking forward, the organisation will host the Midlife & Menopause Summit in October 2026, timed with the Menopause Awareness Month, to bring together practitioners, experts, and women’s voices in a landmark event.
The stigma within
In South Asian families, women who express dissatisfaction in midlife are often told: “But your husband is a good man. Why complain?” Or: “It’s just ageing, everyone goes through it.”
But these dismissals hide a deeper truth: that emotional unavailability, loneliness, and invisibility are just as real as physical symptoms.
By naming these realities, The Sattva Collective empowers women to stop apologising for their needs and start demanding recognition, respect, and resources.
Awareness as empowerment
This Menopause Awareness Month, South Asian women deserve to be seen not as a cultural afterthought, but as central voices in the global conversation.
As Singh notes: “Silence leads to shame. Awareness leads to empowerment. When we speak, we break the cycle for the next generation.”
Moving forward
Eastern Eye readers are invited to support this movement by:
- Talking to mothers, sisters, and daughters about menopause.
- Sharing resources within families and community groups.
-Supporting organisations like The Sattva Collective CIC that are leading change.
This October, let us break the generational silence around menopausebecause every South Asian woman deserves to navigate midlife with dignity, confidence, and compassion.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.